Certified by Founder Lodge
Alexandria Real Estate Equities, Inc.
United States - Pasadena, California
INVESTOR
1 Disclosed Funding Rounds $100,000,000
23 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (REIT), pioneered the life science real estate niche and remains the longest-tenured ow
Company | Date | Round | Raised |
---|---|---|---|
Matchpoint Therapeutics | October, 17 ,2022 | Series A | $100,000,000 |
Ensoma | February, 06 ,2023 | Series B | $85,000,000 |
Function Oncology | April, 13 ,2023 | Series A | $28,000,000 |
Orbital Therapeutics | April, 27 ,2023 | Unknown | $270,000,000 |
Boundless Bio | May, 17 ,2023 | Series C | $100,000,000 |
Solu Therapeutics | August, 01 ,2023 | Seed | $31,000,000 |
Georgiamune Inc. | August, 10 ,2023 | Series A | $75,000,000 |
Alto Neuroscience | November, 22 ,2023 | Series C | $45,000,000 |
Odyssey Therapeutics | December, 06 ,2023 | Series C | $101,000,000 |
Ability Biologics | December, 07 ,2023 | Seed | $12,000,000 |
Tome Biosciences | December, 14 ,2023 | Series B | $213,000,000 |
Remix Therapeutics | January, 04 ,2024 | Unknown | $60,000,000 |
Tr1X | January, 19 ,2024 | Series A | $75,000,000 |
Elo Life Systems | January, 25 ,2024 | Series A | $20,500,000 |
Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
Mirador Therapeutics | March, 26 ,2024 | Unknown | $400,000,000 |
OverT Bio | May, 07 ,2024 | Seed | $16,000,000 |
Delphia Therapeutics | May, 07 ,2024 | Series A | $67,000,000 |
TwoStep Therapeutics | June, 26 ,2024 | Seed | $6,500,000 |
Outpace Bio | August, 02 ,2024 | Series B | $144,000,000 |
Archon Biosciences | October, 31 ,2024 | Seed | $20,000,000 |
Leal Therapeutics | October, 31 ,2024 | Unknown | $45,000,000 |
CrossBridge Bio | November, 05 ,2024 | Unknown | $10,000,000 |